Investors in Nanotechnology

Showing 1-50 out of 4659 matches

National Science Foundation

The National Science Foundation (NSF), established in 1950 and located in Alexandria, Virginia, is an independent federal agency dedicated to advancing fundamental research and education across all scientific and engineering disciplines. With an annual budget of approximately $7.8 billion, the NSF operates America's Seed Fund, which allocates nearly $200 million each year to support startups and small businesses through the Small Business Innovation Research (SBIR) program. This initiative provides non-dilutive funding of up to $1.5 million to assist in research and development efforts, thereby facilitating the transformation of scientific discoveries into commercially viable products and services. By helping to de-risk technology, the NSF plays a crucial role in fostering innovation and addressing societal challenges through scientific advancements.
Made 845 investments in Nanotechnology

U.S. Department of Energy

The U.S. Department of Energy is a government agency established in 1977, located in Washington, D.C. Its primary mission is to ensure the security and prosperity of the nation by tackling energy, environmental, and nuclear challenges. The Department focuses on promoting transformative scientific and technological solutions to address these issues, thereby supporting the country's energy needs and environmental sustainability.
Made 53 investments in Nanotechnology

SOSV

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.
Made 280 investments in Nanotechnology

European Innovation Council

The EIC pilot supports top-class innovators, entrepreneurs, small companies and scientists with bright ideas and the ambition to scale up internationally. It brings together the parts of Horizon 2020 that provide funding, advice and networking opportunities for those at cutting edge of innovation.
Made 69 investments in Nanotechnology

MassChallenge

MassChallenge is a non-equity startup accelerator headquartered in Boston, Massachusetts, with additional locations in Israel, Mexico, Switzerland, Texas, and the UK. Founded in 2009, it focuses on fostering innovation and entrepreneurship by supporting high-potential startups across various industries globally. MassChallenge provides expert mentorship, a tailored curriculum, and access to corporate partners without taking any equity from the startups. Its programs, including specialized initiatives like MassChallenge FinTech and MassChallenge HealthTech, aim to facilitate partnerships between startups and established companies to drive innovation and growth. To date, MassChallenge has helped over 1,200 alumni raise more than $2 billion in funding and create over 65,000 jobs, demonstrating its significant impact on the global innovation ecosystem.
Made 223 investments in Nanotechnology

IndieBio

IndieBio is an accelerator firm established in 2014 and based in San Francisco, California, with an additional office in New York. It specializes in startups that utilize synthetic biology to address significant global challenges. IndieBio runs four-month accelerator programs aimed at both companies and teams with innovative ideas, focusing on seed-stage and early-stage investments. The firm typically invests $250,000, providing $50,000 in exchange for eight percent equity in biotech startups, with the possibility of an additional $25,000 as a convertible loan note. IndieBio prioritizes investments in businesses that leverage biology as the core of their technology, particularly in life sciences, biotechnology, and related fields. The firm favors teams with a minimum of two co-founders and is open to investing in startups from various geographical locations.
Made 114 investments in Nanotechnology

Innovate UK

Innovate UK is a non-departmental public body established in 2007 and based in Swindon, United Kingdom. Funded by a government grant, it supports innovation in science and technology by providing funding services to businesses across various sectors and regions. The organization aims to drive productivity and economic growth by facilitating advancements that contribute to the UK’s economic landscape. In addition to funding, Innovate UK offers a range of services and information related to business and economic development, thereby fostering a supportive environment for innovation.
Made 80 investments in Nanotechnology

Bpifrance

Bpifrance Financement S.A. is a French financial institution that provides a wide range of financing solutions and support services for businesses at various stages of their development. Established in 1980 and based in Maisons-Alfort, France, the company offers medium to long-term loans, export insurance, real estate and equipment leasing, and working capital loans. Bpifrance also invests in startups, small and medium-sized enterprises (SMEs), and mid-cap companies through direct investments and fund management activities. Additionally, it provides consulting services for executives and training for CEOs, aiming to facilitate innovation and growth. Bpifrance was formed from the merger of several entities in July 2013, including OSEO, CDC Entreprises, and FSI, to enhance its role in supporting the financing of the French economy.
Made 52 investments in Nanotechnology

MedTech Innovator

MedTech Innovator is a nonprofit global competition and accelerator based in Los Angeles, California, founded in 2013. It focuses on supporting companies in the medical device, digital health, and diagnostic sectors. The organization aims to enhance patient outcomes by fostering the growth of businesses that contribute to the transformation of the healthcare system. Each year, MedTech Innovator showcases 100 companies that align with key themes identified through surveys of industry leaders. The accelerator's diverse portfolio includes firms involved in consumer healthcare, imaging, remote patient monitoring, clinical studies, and workflow optimization, emphasizing its commitment to advancing innovative healthcare solutions.
Made 34 investments in Nanotechnology

Sequoia Capital

Sequoia Capital, founded in 1972 and based in Menlo Park, California, is a prominent venture capital firm that invests in early to growth stage companies across various sectors, including technology, healthcare, financial services, and consumer services. The firm specializes in supporting startups and emerging growth companies, typically investing between $100,000 and $1 million in seed companies, $1 million to $10 million in early ventures, and $10 million to $100 million in growth investments. Sequoia Capital operates globally, with a presence in regions such as Israel, China, and Southeast Asia, and has built a diverse portfolio that includes notable companies like Airbnb, Alibaba, and JD.com. The firm emphasizes a partnership approach with entrepreneurs, leveraging decades of experience to guide them from initial concept through to public offering and beyond.
Made 92 investments in Nanotechnology

Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm based in Shanghai, China, with additional offices in Beijing, Suzhou, and Hong Kong. Founded in 2006, the firm specializes in investing in early to growth-stage companies across various sectors, including healthcare, information technology, consumer products, media, and clean technology. Qiming has established itself as a leading investment firm in China, managing multiple funds with over $1 billion in assets. The firm focuses on supporting innovative entrepreneurs and companies that demonstrate high growth potential, particularly in the technology and healthcare landscapes. Through its strategic investments, Qiming aims to foster the development of new business models and technologies, contributing to the dynamic entrepreneurial ecosystem in China.
Made 73 investments in Nanotechnology

5Y Capital

5Y Capital is a private equity and venture capital firm based in Shanghai, China, focused on seed, start-up, early venture, and growth capital investments. Founded in 2008 and previously known as Morningside Venture Capital, the firm manages approximately USD 5 billion in dual-currency funds, supported by global investors such as sovereign wealth funds, family offices, and endowments. 5Y Capital primarily invests in various sectors, including healthcare, technology, fintech, media, software, life sciences, and education, with a special emphasis on medical treatment, biotechnology, and digital health. The firm seeks opportunities in China and other emerging markets across Asia and the Pacific, aiming to support entrepreneurs in building innovative companies. 5Y Capital typically makes initial investments exceeding USD 500,000 per portfolio company and operates as a subsidiary of Morningside Group, which has been active in venture capital investments since 1992.
Made 49 investments in Nanotechnology

RA Capital Management

RA Capital Management, L.P. is a Boston-based venture capital firm that specializes in early and multi-stage investments in the healthcare and life sciences sectors. Founded in 2001, the firm focuses on companies developing drugs, medical devices, diagnostics, and biotechnology. RA Capital invests in a range of funding stages, from seed funding to later rounds, and is known for its willingness to invest under $1 million in initial rounds or larger sums in established companies. The firm's investment strategy emphasizes companies with promising technologies and products, particularly in areas like prevention, cost-effective diagnostics, genetic testing, and personalized medicine. The team consists of professionals with backgrounds in biology, chemistry, and medicine, enabling them to provide valuable insights into data, regulatory processes, and market demands. Additionally, RA Capital often seeks to co-invest and take board positions in its portfolio companies, enhancing their strategic growth opportunities.
Made 42 investments in Nanotechnology

Creative Destruction Lab

The Creative Destruction Lab (CDL) is a seed-stage acceleration program founded in 2012 at the Rotman School of Management in Toronto, Canada. It is dedicated to supporting massively scalable, science- and technology-based ventures by providing a unique coaching process focused on specific objectives. CDL connects startups with experienced entrepreneurs and leading scientists across various sectors, including artificial intelligence, healthcare, quantum computing, blockchain, energy, and cleantech. The program has expanded its reach, operating in six cities: Vancouver, Calgary, Toronto, Montreal, Halifax, and New York City, and emphasizes the commercialization of scientific and technological advancements.
Made 108 investments in Nanotechnology

OrbiMed

OrbiMed Advisors LLC is a healthcare-focused investment firm founded in 1989, headquartered in New York City, with additional offices in various global locations. The firm manages approximately $5 billion in assets and specializes in private equity and venture capital investments across the healthcare sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services. OrbiMed invests in companies at various stages, from early startups to established multinationals, and typically seeks to take majority stakes in its private equity investments. The firm employs fundamental analysis to guide its investment decisions and offers a range of financial services, including debt financing and structured capital, to both public and private healthcare companies. OrbiMed's investment strategy encompasses a broad spectrum of healthcare-related opportunities, targeting investments globally, primarily in North America, Europe, and Asia.
Made 72 investments in Nanotechnology

ARCH Venture Partners

ARCH Venture Partners is a private equity and venture capital firm founded in 1986 and based in Chicago, Illinois. It specializes in investing in early-stage and later-stage technology companies, primarily focusing on life sciences, biotechnology, advanced materials, and various tech sectors such as clean technology, software, and communications. The firm is recognized for its role in commercializing innovations developed at academic research institutions and national laboratories. ARCH typically begins with conservative seed investments to mitigate risk, later leading or co-leading funding rounds up to liquidity. With a national scope and a regional focus, it targets underserved geographic markets and seeks to invest in companies addressing neurodegenerative diseases and mental health issues. ARCH has raised over $3 billion through ten venture funds and has invested in more than 150 companies, with a preference for co-founding partnerships with leading scientists and entrepreneurs. Its investors include major corporations, pension funds, and private investors.
Made 92 investments in Nanotechnology

Matrix

Matrix Partners is a venture capital firm established in 1977, with offices in San Francisco, Cambridge, Shanghai, Beijing, Mumbai, and Bangalore. The firm focuses on seed, early-stage, late-stage, and growth capital investments across various sectors, including software, communications, artificial intelligence, fintech, digital health, and clean technology. With a commitment to building long-term relationships with entrepreneurs, Matrix Partners aims to support visionary founders in developing significant, industry-leading companies. The firm has a strong track record, having participated in hundreds of investments, with many of its portfolio companies achieving successful IPOs or profitable mergers and acquisitions. The team at Matrix Partners combines local insights with global expertise, comprising both former entrepreneurs and seasoned investors.
Made 45 investments in Nanotechnology

Khosla Ventures

Khosla Ventures is a venture capital firm established in 2004 by Vinod Khosla, co-founder of Sun Microsystems, and is headquartered in Menlo Park, California. The firm manages over $5 billion and focuses on investing in a diverse range of sectors, including consumer technology, enterprise solutions, education, healthcare, financial services, agriculture, sustainable energy, and robotics. Khosla Ventures provides not only capital but also strategic guidance to entrepreneurs, particularly in early-stage ventures, where it often supports innovative and unconventional projects. The firm seeks to back companies that are driven by breakthrough technologies, with investment sizes ranging from $100,000 to over $20 million. Khosla Ventures maintains a collaborative approach, frequently co-investing with other firms, including Kleiner Perkins, with which it has historical ties.
Made 68 investments in Nanotechnology

Bill & Melinda Gates Foundation

The Bill & Melinda Gates Foundation is an independent non-profit organization based in Seattle, Washington, founded in 2000. It focuses on addressing global inequities by promoting initiatives in education, health, and community support, particularly for low-income families in the Pacific Northwest. The foundation aims to improve health outcomes and alleviate extreme poverty worldwide, funding a variety of programs and strategies to achieve these goals. It operates regional offices in Washington, D.C.; New Delhi, India; Beijing, China; and London, United Kingdom. The foundation's trustees include co-founders Bill and Melinda Gates, along with Warren Buffett, who oversee its grant-making activities and strategic direction.
Made 33 investments in Nanotechnology

IP Group

IP Group, founded in 2001 and based in London, is a venture capital investment firm focused on the commercialization of intellectual property from research-intensive institutions. The firm specializes in providing financial, strategic, and commercial expertise to facilitate the development of businesses in sectors such as clean technology, life sciences, and deep technology. By leveraging its extensive industry knowledge and financial acumen, IP Group effectively identifies and manages suitable intellectual property for commercialization, helping to create value for shareholders and partners. The firm has established a strong track record of delivering positive results through its strategic investments and partnerships, thereby enhancing the potential of innovative companies in its portfolio.
Made 51 investments in Nanotechnology

Lilly Asia Ventures

Lilly Asia Ventures, founded in 2008, serves as the corporate venture capital arm of Eli Lilly and Company, focusing on investments in the life sciences and healthcare sectors, with a particular emphasis on opportunities in China. The firm targets promising companies at various stages of development, from seed to commercialization, and seeks to invest between $5 million and $15 million per round. Lilly Asia Ventures specializes in human therapeutics, medical technology, healthcare services, and broader life sciences, including industrial and agricultural biotechnology. With a preference for taking minority stakes, typically less than 20 percent, the firm aims to partner with companies that exhibit strong management teams and innovative business models. Headquartered in Shanghai, with additional offices in Hong Kong and California, Lilly Asia Ventures is committed to driving innovation in the healthcare landscape across East and South Asia.
Made 39 investments in Nanotechnology

Novo Holdings

Novo Holdings, established in 1999 and based in Copenhagen, is the asset manager for the Novo Nordisk Foundation, overseeing its wealth and investments. The company primarily focuses on the life sciences sector, investing across various stages of company development, from early-stage ventures to established firms. Novo Holdings also manages a diversified portfolio of financial investments, including equity and fixed income securities. It is recognized as a leading life science investor globally and aims to generate long-term value to support the Foundation's grant obligations for medical and scientific research. Additionally, it plays a pivotal role in the Novo Group, maintaining a significant influence over its associated companies, including Novo Nordisk and Novozymes, while ensuring compliance with the group’s shared values and management principles. Through initiatives like Novo Seeds, the firm supports early-stage applied research in Scandinavia, further solidifying its commitment to advancing health and welfare through strategic investments.
Made 58 investments in Nanotechnology

Mission BioCapital

Mission BioCapital is a venture capital firm based in Cambridge, Massachusetts, specializing in investments in early-stage life science and biotechnology companies. Founded in 2009, the firm is recognized for its leadership team's extensive experience in investing in and launching numerous life science ventures. Mission BioCapital operates in regions known for their strong research and venture capital ecosystems, allowing it to leverage local expertise and networks. The firm is committed to providing comprehensive support to its portfolio companies, earning a reputation for its deep engagement and strategic guidance in the life sciences sector.
Made 21 investments in Nanotechnology

Parkwalk Advisors

Parkwalk Advisors Ltd is a venture capital firm based in London, specializing in investments in growth capital and spin-outs from UK universities and research-intensive institutions. Founded in 2009, the firm targets early to growth-stage companies across various sectors, including healthcare, technology, cleantech, and advanced materials, among others. Parkwalk focuses on businesses that possess intellectual property and the freedom to operate, often originating from academic institutions. The firm typically invests between £250,000 and £10 million and is stage agnostic, participating in funding rounds from seed to Series C and beyond. Parkwalk seeks to capitalize on the attractive tax relief offered by the UK government to stimulate investment in innovative companies, thereby promoting economic growth. The firm utilizes extensive networks in academia and venture capital to identify high-quality investment opportunities. In 2017, Parkwalk became a subsidiary of IP Group Plc, enhancing its capacity to commercialize intellectual property.
Made 58 investments in Nanotechnology

Legend Capital

Legend Capital, a subsidiary of Legend Holdings Ltd., was founded in April 2001 and is based in Beijing, China. The firm manages private equity investments across four funds, totaling up to US$700 million, focusing primarily on early-stage ventures and mid-market growth companies. Its investment strategy targets sectors including information technology, telecommunications, media, healthcare, consumer goods, clean technology, and advanced manufacturing, with a strong emphasis on businesses that are either based in China or related to Chinese markets. Legend Capital is known for its active involvement with portfolio companies, providing them with essential business resources and tailored services to enhance development and optimize company performance in the Chinese market. The firm has built a diverse portfolio of over 60 companies, contributing to its reputation as a respected player in China's venture capital industry.
Made 44 investments in Nanotechnology

SMBC Venture Capital

SMBC Venture Capital Co., Ltd. is the private equity and venture capital arm of Sumitomo Mitsui Banking Corporation, established in 2005 and headquartered in Tokyo, Japan, with an additional office in Osaka. The firm specializes in growth capital and buyout investments, focusing on a diverse range of industries, including information technology, life sciences, services, and manufacturing. By leveraging its extensive financial services background, SMBC Venture Capital aims to support the growth and development of innovative companies in these sectors.
Made 42 investments in Nanotechnology

GV

GV Management Company, LLC, formerly known as Google Ventures, serves as the venture capital arm of Alphabet Inc., established in 2009 and headquartered in Mountain View, California, with additional offices in Boston, New York, Cambridge, and London. The firm specializes in growth capital investments across various stages, including seed, early, mid, and late stages, focusing on sectors such as life sciences, healthcare, artificial intelligence, robotics, cyber security, and agriculture. GV has invested in over 300 companies, seeking to support startups that aim to innovate and transform industries. The firm typically invests up to $50 million, with smaller amounts allocated to early-stage ventures. GV provides its portfolio companies with exceptional support by connecting them with Google's resources and talent, leveraging a team of experts in engineering, design, science, and marketing to enhance their growth potential.
Made 47 investments in Nanotechnology

Shenzhen Capital Group

Shenzhen Capital Group Co., Ltd is a venture capital firm established in 1999 by the Shenzhen Government. The company focuses on fostering national industries, enhancing national brands, and facilitating economic transformation through investments in small to medium enterprises and innovative high-tech companies. It targets businesses in their start-up, growth, and transformation stages, primarily within sectors supported by national policies, including information technology, internet, new media, biopharma, new energy, environmental protection, chemical engineering, and high-end equipment manufacturing. With registered capital of 5.42 billion RMB and total assets under management of 338.99 billion RMB, SCGC has built a substantial portfolio, comprising nearly 1,000 companies, with significant investments totaling 43.9 billion RMB. As of April 2019, the firm was recognized as a leader in the venture capital space, with 145 of its portfolio companies successfully listed across 16 global capital markets.
Made 35 investments in Nanotechnology

Andreessen Horowitz

Andreessen Horowitz is a venture capital firm established in 2009 by Marc Andreessen and Ben Horowitz, based in Menlo Park, California. The firm specializes in investing across various stages of startups, from seed to late stage, with a strong emphasis on technology sectors. Its investment focus includes software, cloud computing, enterprise solutions, and consumer Internet, as well as areas intersecting computer science and life sciences, such as digital therapeutics and computational medicine. The firm aims to fund innovative companies that contribute to American dynamism, with investments typically ranging from $50,000 to $50 million. While primarily targeting technology startups, Andreessen Horowitz has a selective approach, avoiding investments in sectors like clean energy and traditional consumer retail.
Made 21 investments in Nanotechnology

Alexandria Venture Investments

Alexandria Venture Investments, LLC is a venture capital firm established in 1996 and headquartered in Pasadena, California. As the strategic investment arm of Alexandria Real Estate Equities, it focuses on providing capital to seed, early-stage, and growth-stage companies within the healthcare sector. The firm emphasizes investments in biopharma, diagnostics, life sciences, research tools, agrifoodtech, and agtech. Alexandria Venture Investments aims to support innovative entities developing breakthrough technologies and therapies, leveraging its extensive industry knowledge and relationships with leading investors. Its approach is characterized by a commitment to fostering innovation and entrepreneurship in the life sciences and technology sectors.
Made 40 investments in Nanotechnology

Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization established in 1982 that serves as a vital capital provider and supporter of technology development in the region. Based in Philadelphia, it has invested over $170 million in more than 2,000 early-stage and established technology companies, fostering innovation primarily in information technology, health, and physical sciences. The organization not only provides financial support but also develops partnerships between universities and industries to accelerate the commercialization of scientific discoveries. By strengthening the local entrepreneurial ecosystem, Ben Franklin Technology Partners plays a crucial role in job creation and economic transformation in Southeastern Pennsylvania.
Made 12 investments in Nanotechnology

M Ventures

M Ventures is an early-stage venture capital firm based in Los Angeles, California, focusing on direct investments in technology companies. Established in 2017, it seeks innovative ideas, technologies, and products that can capitalize on cultural shifts and trends in a diverse global marketplace. The firm primarily invests in information technology and software, targeting companies that have the potential for substantial growth. M Ventures emerged from the merger of two successful seed funds, Cross Culture Ventures and M Ventures, creating a unified approach to identifying and nurturing promising ventures. By concentrating on early-stage opportunities, M Ventures aims to support entrepreneurs in transforming their groundbreaking concepts into impactful businesses.
Made 22 investments in Nanotechnology

Intel

Intel Corporation is a leading global designer and manufacturer of essential technologies for cloud computing, smart devices, and connected systems. The company operates through various segments, including Data Center Group, Internet of Things Group, Mobileye, and Client Computing Group, offering a wide range of products such as microprocessors, chipsets, system-on-chip solutions, and memory products. Intel's innovations extend to high-performance computing for targeted industries, as well as technologies for computer vision and machine learning applications. The firm serves original equipment manufacturers, design manufacturers, and cloud service providers. Founded in 1968 and headquartered in Santa Clara, California, Intel also invests through Intel Capital, which has supported numerous startups in areas like artificial intelligence and cybersecurity, advancing new technologies and solutions. Intel has consistently led the semiconductor market, driven by its commitment to innovation and the development of transformative products that enhance performance, connectivity, and data utilization across various sectors, including automotive and the Internet of Things.
Made 86 investments in Nanotechnology

5AM Ventures

5AM Ventures is a venture capital firm founded in 2002 and headquartered in San Francisco, California, with an additional office in Boston. The firm specializes in seed and early-stage investments, primarily focusing on companies in the life sciences and healthcare sectors, including biopharmaceuticals, medical technology, and advanced research instruments. With a commitment to nurturing innovation, 5AM Ventures plays a pivotal role in supporting emerging companies that are at the forefront of scientific and technological advancements.
Made 48 investments in Nanotechnology

Future Planet Capital

Future Planet Capital is a venture capital firm founded in 2016 and based in London, United Kingdom. The firm specializes in capital growth and invests across various stages, including seed, early, mid, and late venture stages, as well as fund of funds investments. It focuses on companies that aim to commercialize research from UK universities, particularly in sectors addressing climate change, education, healthcare, security, and sustainable growth. By connecting large investors with innovative solutions, Future Planet Capital seeks to profitably tackle some of the world's most pressing challenges while supporting the development of breakthrough technologies.
Made 36 investments in Nanotechnology

Alumni Ventures

Alumni Ventures Group, LLC is a venture capital firm founded in 2013 and based in Manchester, New Hampshire, with additional offices in major cities across North America. The firm specializes in seed, early-stage, and late-stage pre-IPO investments, focusing on companies with an alumni connection and supported by established institutional lead investors. Alumni Ventures aims to provide accredited investors, particularly alumni from top entrepreneurial schools, with access to diversified venture portfolios that span various sectors and geographic regions. The firm typically invests between $0.01 million and $3 million and does not require board or observer seats in its portfolio companies. Through its managed fund families, Alumni Ventures enables investors to participate in a collaborative investment approach, fostering connections among alumni while facilitating investment opportunities in innovative ventures.
Made 34 investments in Nanotechnology

DCVC

DCVC is a venture capital firm based in Palo Alto, California, founded in 2010. The firm specializes in investing in seed and early-stage companies across various sectors, including artificial intelligence, exascale computing, climate technology, engineering, materials science, robotics, space, water, biology, defense, and security. With a team of experienced venture capitalists, technology entrepreneurs, and engineers, DCVC has a proven track record, having invested in over 150 companies and achieved 40 significant exits. In 2018, the firm expanded its focus with the launch of DCVC Bio, which invests in early-stage startups in computational biology. This branch targets innovations in synthetic biology, medicine, and agriculture, emphasizing teams that leverage advancements in genetic sequencing, artificial intelligence, and automation to drive transformative changes in the life sciences. Both divisions of DCVC are committed to supporting entrepreneurs who are advancing technology and creating impactful solutions in their respective fields.
Made 43 investments in Nanotechnology

High-Tech Gründerfonds

High-Tech Gründerfonds Management GmbH is a venture capital firm based in Bonn, Germany, specializing in early-stage investments in high-tech startups. Established in 2005, the firm focuses on technology-driven companies across various sectors, including information and communication technology, life sciences, healthcare, automation, and cleantech. HTGF typically invests in companies that have been operational for no more than one year, aiming to contribute up to €0.6 million in initial funding and up to €3 million in follow-on financing. The firm seeks a minority stake, generally around 15%, and provides a subordinated loan convertible into equity, with deferred interest for up to four years to support liquidity. With a total investment volume of approximately €895.5 million across three funds, HTGF has successfully supported over 500 startups and attracted more than €2 billion in follow-on investments from external sources. The firm's investors include notable public and private entities, underscoring its role as a key player in fostering innovation and growth within the German startup ecosystem.
Made 47 investments in Nanotechnology

Global Brain

Global Brain is a Tokyo-based venture capital firm founded in 1998, specializing in early-stage investments across various sectors, including e-commerce, software, gaming, media, IoT, education, entertainment, and fintech. The firm has expanded its investment activities to the US and Asia, targeting series A-stage technology companies. Since its inception, Global Brain has invested in approximately 30 companies, achieving seven initial public offerings and seven mergers and acquisitions. The firm supports its portfolio companies by providing not only capital but also strategic guidance, partnerships, and team-building resources to help them reach their milestones. Global Brain is particularly adept in e-commerce, operating a platform called EC-PLANET, which encompasses several group companies, including a large online sports goods store and a logistics firm offering comprehensive fulfillment services. This network, along with Global Brain's connections to established Japanese companies, facilitates market entry for US and Asian businesses into Japan.
Made 16 investments in Nanotechnology

Oxford Science Enterprises

Oxford Science Enterprises is a venture capital firm based in Oxford, United Kingdom, specializing in seed and Series A investments. Established in 2015, the firm focuses on spin-outs from the University of Oxford, targeting sectors such as life sciences, healthcare, biotechnology, cleantech, and advanced technology. Oxford Science Enterprises aims to build science-based businesses that address significant global challenges, including nuclear fusion, quantum computing, and the development of treatments for infectious diseases. The firm has raised over £600 million to foster a robust technology ecosystem, leveraging its extensive network of investors, entrepreneurs, and industry experts to support co-investment, business development, and talent acquisition.
Made 26 investments in Nanotechnology

Sofinnova Partners

Sofinnova Partners is an independent venture capital firm headquartered in Paris, France, with a focus on the life sciences sector. Established in 1972, the firm has financed nearly 500 companies over its 45-year history, primarily investing in start-ups, early-stage companies, corporate spin-offs, and occasionally turnaround situations. Sofinnova Partners actively sources investment opportunities, often taking the lead as the first institutional investor in Series A financings. The firm plays a significant role in guiding its portfolio companies, participating on their boards, and supporting them from the formation phase through to exit. While its primary investment focus is in Europe, the firm also makes select investments globally, concentrating on healthcare and sustainability sectors within life sciences, including biopharmaceuticals, biotech, medical devices, and industrial biotechnology.
Made 44 investments in Nanotechnology

Mitsubishi UFJ Capital

Mitsubishi UFJ Capital Co., Ltd. is a venture capital firm based in Tokyo, Japan, established in 1974. The firm focuses on seed, development stage, and start-up investments, primarily targeting sectors such as healthcare, biotechnology, information technology, electronics, and high technology. It aims to invest in companies relevant to the Japanese market and actively engages in investment syndication for Japanese opportunities. In addition to its domestic focus, Mitsubishi UFJ Capital also makes venture investments in the United States. The firm manages several venture capital funds, including those dedicated to life sciences and technology sectors, further diversifying its investment portfolio. With additional offices in Osaka and Nagoya, Mitsubishi UFJ Capital plays a significant role in advancing innovation and growth within its targeted industries.
Made 53 investments in Nanotechnology

Sustainable Development Technology Canada

Sustainable Development Technology Canada (SDTC) is a venture capital investment firm based in Ottawa, established in 2001. The organization focuses on funding and supporting Canadian cleantech projects, helping companies advance innovative technologies to market. SDTC's investments span various sectors, including agriculture, energy efficiency, green buildings, transportation, and waste management. By fostering the growth of these companies, SDTC aims to create jobs, stimulate economic growth, and generate export opportunities while delivering environmental and health benefits to Canadians. Operating independently, SDTC collaborates with a diverse network of partners from private industry, academia, and government, both domestically and internationally, to enhance the impact of its initiatives. The organization receives funding from the Government of Canada to further its mission.
Made 47 investments in Nanotechnology

Samsung Venture Investment

Samsung Venture Investment Corporation (SVIC), founded in 1999 and headquartered in Seoul, is the corporate venture capital arm of Samsung Electronics. The firm focuses on investing in emerging technology startups across various sectors, including artificial intelligence, robotics, augmented and virtual reality, semiconductors, cybersecurity, and digital health, among others. With over $1.8 billion under management and an annual investment budget of $250 million, SVIC targets early-stage startups to pre-IPO companies. The firm has a global presence, with offices in key innovation hubs such as the San Francisco Bay Area, Boston, London, Tel Aviv, Bangalore, Tokyo, and Beijing. Through its strategic investments, SVIC aims to drive the discovery and development of new businesses and technologies that will shape the future.
Made 40 investments in Nanotechnology

Par Equity

Par Equity LLP is a venture capital firm based in Edinburgh, United Kingdom, specializing in early-stage and growth investments, particularly in the technology sector. Founded in 2008, the firm targets small and medium-sized enterprises (SMEs) with high growth potential, including those in digital health technology. Par Equity primarily invests between £0.25 million and £2.5 million in companies with enterprise values up to £10 million, focusing on opportunities that involve proprietary technology and proven commercial products poised for transatlantic expansion. The firm aims to support Scottish companies looking to enter the United States market while also attracting U.S. businesses to Scotland. Par Equity operates an additional office in San Francisco, California, enhancing its capability to facilitate cross-continental investment opportunities.
Made 29 investments in Nanotechnology

Pfizer

Pfizer Inc., founded in 1849 and based in the United States, is one of the world's largest pharmaceutical companies, specializing in the development and sale of prescription drugs and vaccines. With annual sales nearing $50 billion, the company focuses on improving health outcomes by providing safe, effective, and affordable medicines. Pfizer has a diverse portfolio that includes leading products such as the pneumococcal vaccine Prevnar 13, the cancer treatment Ibrance, and the cardiovascular medication Eliquis. The majority of its sales come from prescription drugs and vaccines, with nearly half of its revenue generated from international markets, particularly emerging economies. Pfizer is committed to addressing significant health care challenges through scientific innovation and aims to ensure access to essential health care services for people worldwide.
Made 52 investments in Nanotechnology

HAX

HAX is a venture capital program that accelerates hardware startups through an intensive support system, operating primarily in Shenzhen and San Francisco. Founders begin their journey in Shenzhen, focusing on rapid prototyping and the development of various aspects of their business, including marketing strategies and business plans. Once they refine their products, teams transition to San Francisco, where the emphasis shifts to business development, fundraising, and establishing connections with corporates, investors, and media. HAX also offers specialized programs like HAX Growth, a seven-week bootcamp for launching B2C and B2B hardware startups, and HAX Boost, which helps selected teams enhance their sales and marketing strategies over six weeks. Founded in 2012, HAX is part of SOSV and targets technology companies that aim to create meaningful advancements in sustainability, industrial automation, and human health. The program continues to support startups beyond the initial phases, providing resources and guidance as they grow.
Made 40 investments in Nanotechnology

Hillhouse Investment Group

Hillhouse Investment Group, founded in 2005 and headquartered in Hong Kong, is a private equity firm that specializes in a wide range of investments, from seed funding to buyouts and listed equities. The firm primarily focuses on opportunities in Asia but also selectively invests in North America and Europe. Hillhouse’s investment strategy is stage-agnostic, allowing it to invest in companies at various stages of growth, from startups to established public entities. Its portfolio spans several sectors, including consumer, technology, media, telecommunications, healthcare, energy transition, and advanced manufacturing. In healthcare, Hillhouse emphasizes biotechnology, medical devices, and pharmaceuticals. The firm is recognized for its commitment to independent research and employs sector experts to guide its investment decisions, aiming for long-term results rather than short-term gains.
Made 36 investments in Nanotechnology

Scottish Enterprise

Scottish Enterprise is Scotland's primary economic development agency, operating as a non-departmental public body of the Scottish Government. Its mission is to foster economic growth by supporting the development of innovative, high-wage industries with a strong international presence. The organization plays a crucial role in assisting small and medium-sized enterprises (SMEs) in securing financing, helping them engage with funders and access the necessary capital for expansion. Scottish Enterprise invests through its arm, the Scottish Investment Bank, which focuses on various sectors, including renewable energy, life sciences, and creative industries. The firm engages in both direct and fund-of-fund investing, typically providing financial support in the form of equity or loans ranging from £0.01 million to £10 million. Additionally, it collaborates with public and private sectors and works alongside UK and international investors to enhance the funding landscape for Scottish businesses. Through these initiatives, Scottish Enterprise aims to create a sustainable economic impact and strengthen the funding market within Scotland.
Made 42 investments in Nanotechnology

In-Q-Tel

In-Q-Tel, founded in 1999 and based in Tysons, Virginia, is a not-for-profit venture capital firm that partners with innovative companies to provide advanced technologies to the U.S. Intelligence Community, including the Central Intelligence Agency. The organization focuses on accelerating the development and delivery of vital solutions that enhance national security. In-Q-Tel invests in a diverse range of technology sectors, such as artificial intelligence, biotechnology, data analytics, and the Internet of Things, seeking to support startups that can deliver timely innovations essential for intelligence and defense operations. By identifying and fostering cutting-edge technology, In-Q-Tel plays a crucial role in equipping government agencies with the tools necessary to fulfill their missions effectively.
Made 27 investments in Nanotechnology